格隆汇9月22日丨根据联交所最新权益披露资料显示,2022年9月19日,信达生物(01801.HK)获The Capital Group Companies, Inc.在场内以每股均价25.873港元增持194.3万股,涉资约5027.12万港元。
增持后,The Capital Group Companies, Inc.最新持股数目为9235.44万股,持股比例由5.92%上升至6.04%。
格隆汇9月22日丨根据联交所最新权益披露资料显示,2022年9月19日,信达生物(01801.HK)获The Capital Group Companies, Inc.在场内以每股均价25.873港元增持194.3万股,涉资约5027.12万港元。
增持后,The Capital Group Companies, Inc.最新持股数目为9235.44万股,持股比例由5.92%上升至6.04%。
Risk disclosure: The above content only represents the opinion of the authors or guests, and does not represent any positions of Futu or constitute any investment advice on the part of Futu. Before making any investment decision, investors should consider the risk factors related to investment products based on their own circumstances and consult professional investment advisers where necessary. Futu makes every effort to verify the authenticity, accuracy, and originality of the above content, but does not make any guarantees or promises.